Cancer is fundamentally a genetic disease caused by alterations in the genes that regulate cell growth and reproduction. These alterations, or mutations, can occur due to several factors, such as

On 17th October 2024, the Mercure Cardiff Holland House Hotel in Cardiff will host a prestigious black-tie event recognising the key contributors to the STEM (Science, Technology, Engineering, and Maths)

Your genome, an extensive set of genetic material composed of approximately 3 billion pieces of DNA, serves as the master instruction manual for your body. Every cell within your body

Genetic testing involves medical tests to identify specific mutations in a person’s genes. These tests, which are continually evolving, have diverse applications, including assessing cancer risk. Predictive genetic testing, in

Guardant Health Japan Corp announced its submission of a regulatory application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for the approval of the Guardant360® CDx comprehensive genomic profiling

In cancer treatment, understanding the tumour is crucial for guiding therapy. The current standard for tumour analysis is the invasive needle or surgical biopsy. However, these biopsies have limitations, including

EDX Medical is introducing a state-of-the-art testing service in the UK to identify the risk of hereditary cancer. This comprehensive hereditary germline cancer test is meticulously designed to predict if

EDX Medical, based in Cambridge, UK, is launching a new diagnostic tool in the UK designed to identify patients’ risk of developing hereditary cancer. This diagnostic tool performs germline testing,